ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Xeris Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Xeris Pharmaceuticals, INC. (Xeris Pharmaceuticals, INC. 401(k) Plan · EIN 20-3352427 · PN 002): $35.79M net assets, 403 active participants, and $21.84 per $10,000 (21.84 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorXeris Pharmaceuticals, INC.
Filing IdentifierXeris Pharmaceuticals, INC. 401(k) Plan · EIN 20-3352427 · PN 002
Plan Category & State401(k) Defined Contribution (IL)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$35.79M
Active Participants403
Direct Admin Fee Rate$21.84 per $10,000 (21.84 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderT. Rowe Price
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI